Home Write to the Editor
Biochemistry news, hot off the press Society news, hot off the press Conferences, meetings, seminars, courses Jobs Grants, awards Read or write one! Current edition of The Biochemist

10 October 2013

Researchers ‘switch off’ neurodegeneration in mice

Researchers have identified a major pathway leading to brain cell death in mice with neurodegenerative disease. They were able to block the pathway, preventing brain cell death and increasing survival in the mice.

In human neurodegenerative diseases, including Alzheimer’s, Parkinson’s and prion diseases, proteins ‘mis-fold’ in a variety of different ways resulting in the build-up of mis-shapen proteins. These form the plaques found in Alzheimer’s and the Lewy bodies found in Parkinson’s disease.

The researchers at the Medical Research Council (MRC) Toxicology Unit at the University of Leicester studied mice with neurodegeneration caused by prion disease. These mouse models currently provide the best animal representation of human neurodegenerative disorders, where it is known that the build-up of mis-shapen proteins is linked with brain cell death.

They found that the build-up of mis-folded proteins in the brains of these mice activates a natural defence mechanism in cells, which switches off the production of new proteins. This would normally switch back ‘on’ again, but in these mice the continued build-up of mis-shapen protein keeps the switch turned ‘off’. This is the trigger point leading to brain cell death, as those key proteins essential for nerve cell survival are not made.

By injecting a protein that blocks the ‘off’ switch of the pathway, the scientists were able to restore protein production, independently of the build-up of mis-shapen proteins, and halt the neurodegeneration. The brain cells were protected, protein levels and synaptic transmission (the way in which brain cells signal to each other) were restored and the mice lived longer, even though only a very small part of their brain had been treated.

Mis-shapen proteins in human neurodegenerative diseases, such as Alzheimer’s and Parkinson’s diseases, also over-activate this fundamental pathway controlling protein synthesis in the brains of patients, which represents a common target underlying these different clinical conditions. The scientists’ results suggest that treatments focused on this pathway could be protective in a range of neurodegenerative disease in which mis-shapen proteins are building up and causing neurons to die.

Professor Giovanna Mallucci, who led the team, said, “What’s exciting is the emergence of a common mechanism of brain cell death, across a range of different neurodegenerative disorders, activated by the different mis-folded proteins in each disease. The fact that, in mice with prion disease, we were able to manipulate this mechanism and protect the brain cells means we may have a way forward in how we treat other disorders. Instead of targeting individual mis-folded proteins in different neurodegenerative diseases, we may be able to target the shared pathways and rescue brain cell degeneration irrespective of the underlying disease.”

Professor Hugh Perry, chair of the MRC’s Neuroscience and Mental Health Board, said, “Neurodegenerative diseases such as Alzheimer’s and Parkinson’s are debilitating and largely untreatable conditions. Alzheimer’s disease and related disorders affect over seven million people in Europe, and this figure is expected to double every 20 years as the population ages across Europe. The MRC believes that research such as this, which looks at the fundamental mechanisms of these devastating diseases, is absolutely vital. Understanding the mechanism that leads to neuronal dysfunction prior to neuronal loss is a critical step in finding ways to arrest disease progression.”

The paper, ‘Sustained translational repression by eIF2a-P mediates prion neurodegeneration’ by Mallucci et al is published in Nature.



 
Biochemical Society Homepage More top news stories
New protein structure could help treat Alzheimer’s and related diseases
Scientists discover new, noncommittal mechanism of drug resistance
Researchers identify a treatment that prevents tumour metastasis